About Dr. Benjamin Chen
Dr. Benjamin Chen is the CEO and Chairman of Immune Targeting Systems (ITS), a company in the field of Immunology which is dedicating to creating vaccines for viral infections. During his career Dr. Chen has worked as a scientist, banker and entrepreneur. In addition to his duties at ITS he manages his own practice at Ignatius Transaction Partners. He has significant experience in building research teams in the fields of immunology, gene therapy and stem cell biology for multinational pharmaceutical companies and biotechnology start-ups. Dr. Chen received his Ph.D. in Immunology /Cancer Biology from the University of Wisconsin-Madison and completed his Post-Doctoral training in Cell Biology/Immunology from Stanford University School of Medicine.